GFO Issue 135, Article Number: 3

N/A

Article Type:
News
Author:
Bernard Rivers
Date: 2010-12-16

ABSTRACT

ABSTRACT Details are provided of the Board's decision regarding each eligible Round 10 proposal.

Based on advice from the TRP, the Board divided eligible Round 10 proposals into five categories, as follows:

Category 1: Approved proposals requiring no or minor clarifications; any clarifications need to be provided within eight weeks and then given a final approval by the TRP Chair or Vice-Chair.
Category 2: Proposals that are approved subject to the required clarifications being provided within a limited timeframe (six weeks for the applicant to provide an initial detailed response to the TRP queries, and a further three months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in a future round following major revision.
Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.

The Board approved all proposals in Categories 1, 2 and 2B. Table 8 provides a summary of the Round 10 results by category. Tables 9 and 10 show the results for each applicant.

Table 8: Round 10 results by category

Category	Number of proposals	TRP-recommended funding
Category	Number of proposals	(Years 1-2)	(Years 1-5)
Approved: Category 1	3	$0.05 b.	$0.14 b.
Approved: Category 2	49	$1.03 b.	$2.73 b.
Approved: Category 2B	27	$0.65 b.	$1.85 b.
Subtotal: All Approved Proposals:	79	$1.73 b.	$4.72 b.
Not Approved: Category 3	56	$1.64 b.	$4.21 b.
Not Approved: Category 4	15	$0.78 b.	$2.22 b.
Not Approved: Parts of Category 1, 2 and 2B proposals not recommended for funding *	n/a	$0.14 b.	$0.48 b.
Subtotal: All Non-Approved Proposals:	71	$2.56 b.	$6.91 b.
Total: All Proposals	150	$4.30 b.	$11.63 b.

* This refers to a situation where a disease proposal with an HSS request attached has been submitted, and the TRP has recommended, and the Board has approved, either the disease proposal or the HSS request, but not both.

Table 9: Round 10 results, by country

Notes: 1. In the following table, DP = disease part. 2. For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.

Applicant		Disease component	Applicant type	Decision	Cate-gory	Cost
Applicant		Disease component	Applicant type	Decision	Cate-gory	(Years 1-2)	(Years 1-5)
Afghanistan		TB (DP + HSS part)	CCM	Approved	2	€ 16,132,533	€ 23,330,719
Angola		HIV	CCM	Approved	2B	$25,877,952	$68,884,971
Angola		Malaria	CCM	Approved	1	$40,435,549	$111,239,055
Argentina		HIV MARPs	CCM	Approved	2	$4,933,812	$12,500,000
Armenia		HIV MARPs	CCM	Not approved	3	€ 2,328,230	€ 4,817,816
Armenia *		TB (DP)	CCM	Approved	2	€ 3,310,881	€ 8,881,651
Armenia		TB (HSS part)	CCM	Not approved	n/a	€ 1,180,614	€ 2,159,904
Azerbaijan		HIV MARPs	CCM	Not approved	3	$3,546,724	$12,466,986
Azerbaijan		Malaria	CCM	Not approved	3	€ 1,880,538	€ 3,571,100
Bangladesh **		TB	CCM	Approved	2B	$11,677,496	$98,543,757
Belize		HIV MARPs	CCM	Not approved	3	$2,602,746	$6,722,026
Belize		TB	CCM	Not approved	4	$2,823,065	$5,960,681
Benin		HIV	CCM	Not approved	3	€ 11,286,254	€ 21,692,352
Benin		TB	CCM	Not approved	3	€ 993,858	€ 2,274,009
Bosnia & Herz.		HIV	CCM	Not approved	4	€ 2,800,310	€ 5,497,810
Botswana		HIV	CCM	Not approved	3	$47,926,893	$137,642,491
Botswana		TB	CCM	Not approved	3	$10,828,604	$25,258,210
Brazil		HIV MARPs	CCM	Not approved	3	$5,000,000	$12,500,000
Burkina Faso		HIV (DP)	CCM	Approved	2B	€ 38,993,903	€ 97,448,392
Burkina Faso		HIV (HSS part)	CCM	Not approved	n/a	€ 10,272,650	€ 24,384,963
Burundi		TB	CCM	Not approved	3	$4,830,351	$13,212,893
Cambodia		HIV	CCM	Not approved	3	$23,124,597	$47,452,279
Cambodia		TB (DP + HSS part)	CCM	Not approved	3	$47,313,760	$132,570,309
Cameroon		HIV	CCM	Approved	2B	€ 30,200,540	€ 97,411,942
Cape Verde		Malaria	CCM	Approved	2B	€ 968,724	€ 1,414,366
Central Af. Rep.		HIV (DP + HSS part)	CCM	Not approved	3	€ 29,077,778	€ 64,570,395
Chad		HIV	CCM	Not approved	3	€ 31,801,787	€ 94,985,597
Chad		TB (DP + HSS part)	CCM	Not approved	3	€ 11,599,749	€ 22,450,241
China		Malaria	CCM	Approved	2B	$5,830,102	$15,704,363
Colombia		TB	CCM	Approved	2B	$5,390,584	$11,271,656
Congo Rep.		HIV	CCM	Not approved	3	€ 4,674,974	€ 9,978,943
Congo DR		HIV	CCM	Not approved	3	$111,533,674	$295,297,357
Congo DR		Malaria	CCM	Approved	2	$73,922,870	$185,122,386
Cote d'Ivoire		HIV (DP + HSS part)	CCM	Not approved	3	€ 57,632,004	€ 133,432,755
Djibouti		TB	CCM	Approved	2	€ 2,461,552	€ 6,080,117
Dominican Rep.		HIV MARPs	CCM	Not approved	4	$4,950,940	$12,496,996
Eritrea *		HIV (DP + HSS part)	CCM	Approved	2	$20,818,140	$59,897,311
Eritrea * **		TB	CCM	Approved	2B	$7,316,801	$22,815,431
Ethiopia		HIV	CCM	Not approved	3	$88,149,150	$176,458,326
Ethiopia	Malaria (DP + HSS part)		CCM	Not approved	3	$97,848,890	$245,989,480
Ethiopia		TB	CCM	Not approved	3	$21,107,334	$82,169,387
Georgia		HIV MARPs	CCM	Approved	2	€ 3,105,210	€ 8,860,077
Georgia		TB	CCM	Approved	2	€ 7,695,603	€ 21,727,729
Ghana		HIV (DP + HSS part)	CCM	Not approved	4	$499,428,723	$1,420,138,447
Ghana *		TB	CCM	Approved	2B	$31,897,744	$77,418,445
Guinea		HIV (DP + HSS part)	CCM	Approved	2B	$20,877,516	$56,875,437
Guinea		Malaria	CCM	Approved	2B	$32,046,938	$46,625,648
Guinea Bissau		HIV (DP + HSS part)	CCM	Not approved	3	€ 26,167,631	€ 63,815,647
Guyana		TB	CCM	Not approved	4	$486,607	$1,050,801
Honduras		TB	CCM	Approved	2B	$6,030,951	$12,402,425
India		HIV	CCM	Not approved	3	$21,412,956	$61,404,090
Indonesia		TB (DP + HSS part)	CCM	Approved	2	$47,727,271	$157,544,680
Iran		Malaria	CCM	Approved	2	$9,363,548	$19,578,464
Jordan		TB	CCM	Approved	2	$2,078,829	$4,666,284
Kazakhstan		HIV MARPs	CCM	Approved	2	$2,404,755	$12,449,062
Kenya		HIV	CCM	Approved	2B	$93,376,285	$345,103,871
Kenya		Malaria	CCM	Approved	2	$49,979,579	$138,370,324
Kyrgyz Rep.		HIV	CCM	Approved	2	$11,207,840	$41,480,486
Kyrgyz Rep.		TB	CCM	Not approved	3	$3,842,777	$5,659,777
Lao PDR		TB (HSS part)	CCM	Not approved	n/a	$8,155,754	$17,158,018
Lao PDR **		TB (DP)	CCM	Approved	2	$3,255,999	$12,887,910
Lesotho		HIV	CCM	Not approved	3	$29,594,699	$65,273,286
Liberia	Malaria (DP + HSS part)		CCM	Approved	2	$28,698,063	$68,892,692
Liberia		TB	CCM	Approved	2B	$2,862,226	$16,061,899
Macedonia		HIV MARPs	CCM	Approved	1	€ 2,825,259	€ 9,407,934
Macedonia		TB	CCM	Approved	2	€ 2,901,528	€ 6,112,713
Madagascar		HIV (DP + HSS part)	CCM	Not approved	3	$46,050,649	$110,739,971
Malawi		HIV	CCM	Not approved	3	$164,254,176	$561,450,164
Malaysia		HIV MARPs	CCM	Approved	2B	$4,672,630	$12,405,288
Maldives		HIV MARPs	CCM	Not approved	3	$2,880,814	$8,044,746
Mali		Malaria	CCM	Approved	2B	€ 24,827,735	€ 94,873,243
Mali		TB	CCM	Approved	2	€ 8,053,957	€ 13,773,341
Mauritius		HIV MARPs	CCM	Not approved	3	$2,870,148	$12,435,364
Moldova		HIV MARPs	CCM	Not approved	3	$3,849,298	$12,491,713
Mongolia		HIV	CCM	Not approved	4	$2,218,185	$7,248,739
Mongolia **		TB (DP + HSS part)	CCM	Approved	2	$3,696,354	$9,052,049
Morocco		HIV	CCM	Approved	2	$14,672,516	$43,597,649
Morocco		TB	CCM	Approved	2	$5,014,439	$10,795,334
Mozambique		HIV	CCM	Not approved	3	$54,163,105	$131,214,912
Mozambique		TB	CCM	Not approved	3	$25,407,092	$69,822,783
Namibia		HIV	CCM	Not approved	4	$15,248,614	$44,292,453
Namibia		TB	CCM	Approved	2	$12,524,672	$32,994,241
Nepal		HIV	CCM	Approved	2	$16,150,553	$57,273,249
Nicaragua		TB	CCM	Not approved	3	$4,106,578	$8,247,665
Niger		HIV	CCM	Not approved	3	€ 30,335,989	€ 73,945,907
Niger		Malaria	CCM	Not approved	3	€ 72,627,052	€ 130,641,962
Niger		TB (DP + HSS part)	CCM	Approved	2B	€ 19,035,383	€ 42,226,096
Nigeria		HIV (DP + HSS part)	CCM	Not approved	4	$97,491,288	$383,708,645
Pakistan *		Malaria (DP)	CCM	Approved	2B	$23,395,667	$51,516,709
Pakistan		Malaria (HSS part)	CCM	Not approved	n/a	$15,199,740	$21,594,900
Panama		HIV MARPs	CCM	Approved	2	$4,202,744	$10,273,513
Papua NG *		HIV (DP + HSS part)	CCM	Approved	2	$23,419,727	$46,697,052
Peru		HIV MARPs	CCM	Approved	2	$4,999,999	$12,499,997
Peru		Malaria	CCM	Not approved	3	$2,835,863	$7,741,937
Peru		TB	CCM	Not approved	3	$15,481,203	$29,837,075
Russian Fed.		TB	CCM	Approved	2B	$63,472,958	$126,926,245
Russian Fed.		TB	Sub-CCM	Not approved	4	€ 20,170,145	€ 36,360,264
Sao Tome & P.		HIV	CCM	Approved	2	$1,279,852	$2,476,713
Senegal		Malaria	CCM	Approved	2	€ 21,650,781	€ 62,865,723
Senegal * **		TB	CCM	Approved	2	€ 6,335,035	€ 17,460,725
Sierra Leone		Malaria	CCM	Approved	2	$23,255,609	$62,649,856
Sierra Leone		TB (DP + HSS part)	CCM	Not approved	3	$34,333,373	$77,234,629
Somalia	Malaria (DP + HSS part)		Non-CCM	Approved	2	$39,333,002	$84,550,325
Somalia * **		TB	Non-CCM	Approved	2B	$14,213,393	$58,380,928
South Africa		HIV	CCM	Approved	2	$128,481,275	$302,717,719
Sri Lanka		TB (DP + HSS part)	CCM	Not approved	3	$11,845,852	$25,088,859
Sudan North		HIV	CCM	Approved	2	$21,944,538	$61,919,606
Sudan North		Malaria	CCM	Approved	2B	$61,256,082	$182,841,841
Sudan South		HIV	Sub-CCM	Not approved	4	$65,528,320	$135,697,425
Sudan South		Malaria	Sub-CCM	Approved	2	$26,486,653	$98,618,453
Sudan South		TB	Sub-CCM	Not approved	3	$16,374,061	$50,114,047
Swaziland		HIV	CCM	Not approved	3	$34,723,593	$89,609,304
Swaziland **		TB	CCM	Approved	2	$11,202,195	$39,004,228
Syria *		HIV MARPs	CCM	Approved	2B	$1,723,169	$3,396,722
Tajikistan		HIV	CCM	Not approved	3	$20,521,257	$64,745,498
Tajikistan		TB	CCM	Not approved	3	$49,913,253	$115,418,678
Tanzania		HIV	CCM	Not approved	3	$50,880,157	$113,178,230
Tanzania		TB	CCM	Not approved	3	$33,201,781	$68,786,103
Thailand		HIV	CCM	Approved	2	$15,398,249	$42,088,572
Thailand *		Malaria	CCM	Approved	2B	$32,500,432	$78,378,690
Thailand		TB	CCM	Approved	2	$12,344,773	$31,716,829
Timor-Leste		HIV	CCM	Approved	1	$6,798,682	$14,254,688
Timor-Leste *		Malaria	CCM	Approved	2B	$7,170,680	$22,349,915
Timor-Leste		TB	CCM	Not approved	3	$2,706,769	$9,661,901
Togo		HIV	CCM	Not approved	3	€ 6,280,885	€ 16,083,684
Tunisia		HIV MARPs	CCM	Not approved	3	$4,144,950	$12,499,365
Uganda		HIV (DP)	CCM	Not approved	n/a	$55,834,292	$217,300,859
Uganda		HIV (HSS part)	CCM	Approved	2	$17,917,965	$25,251,193
Uganda		Malaria	CCM	Approved	2	$53,167,057	$155,963,673
Uganda		TB	CCM	Approved	2	$10,391,585	$24,757,129
Ukraine		HIV	CCM	Approved	2	$95,842,099	$305,535,421
Uruguay		HIV MARPs	CCM	Approved	2	$3,953,375	$9,572,417
Uzbekistan		HIV	CCM	Approved	2	$9,519,645	$14,828,347
Vietnam		HIV (DP)	CCM	Not approved	n/a	$45,071,739	$188,864,423
Vietnam		HIV (HSS part)	CCM	Approved	2B	$42,102,165	$86,636,150
Yemen		HIV (DP + HSS part)	CCM	Not approved	3	$14,565,766	$32,312,943
Zambia *		HIV	CCM	Approved	2	$102,851,986	$259,216,608
Zanzibar (Tanz.)		TB	CCM	Approved	2	$2,633,434	$5,912,925
Zimbabwe		HIV (DP + HSS part)	CCM	Not approved	3	$118,402,303	$342,054,472
Zimbabwe		Malaria	CCM	Approved	2	$14,550,666	$24,960,569
Zimbabwe		TB	CCM	Not approved	3	$12,193,205	$25,507,117
Total – 135 country-based proposals

* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal. ** These are consolidated proposals. The TRP-recommended funding has been reduced to remove amounts included in the proposals for existing, already funded programmes.

Table 10: Round 10 results for regional applicants

Note: For approved proposals, the costs shown in the last two columns are the amounts recommended by the TRP. For proposals that were not approved, the costs are the amounts requested by the applicant.

Applicant	Disease component	Applicant type	Decision	Cate-gory	Cost
Applicant	Disease component	Applicant type	Decision	Cate-gory	Years 1-2	Years 1-5
AMREF (Re Burundi, Ethiopia, Kenya, Tanzania, Uganda)	TB	RO	Not approved	4	$29,868,200	$63,996,437
APN+ (Re Bangladesh, Indonesia, Lao PDR, Nepal, Pakistan, Philippines, Viet Nam) *	HIV	RO	Approved	2	$1,200,000	$3,000,000
ASICAL (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay)	HIV MARPs	RO	Not approved	3	$4,827,281	$11,149,346
CONGA (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama)	HIV MARPs	RO	Not approved	4	$4,506,212	$12,451,594
ECSA (Re Zambia, Zimbabwe)	TB	RO	Not approved	3	$3,322,054	$14,593,861
GLIA (Re Burundi, Congo DR, Kenya, Rwanda, Tanzania, Uganda)	HIV MARPs	RO	Not approved	4	$4,873,647	$12,499,735
HIVOS-SA (Re Lesotho, Mauritius, Namibia, South Africa, Swaziland)	HIV	RO	Not approved	4	$12,130,614	$36,066,771
ISEAN-HIVOS (Re Indonesia, Malaysia, Philippines, Timor-Leste)	HIV MARPs	RO	Approved	2B	$4,767,802	$12,473,395
MENAHRA (Re Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, West Bank and Gaza, Pakistan, Syria, Tunisia) *	HIV MARPs	RO	Approved	2B	$3,209,492	$8,352,698
Meso (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama)	HIV	RCM	Not approved	3	$7,868,536	$23,214,775
MOZIZA (Re Mozambique, South Africa, Zimbabwe)	Malaria	RCM	Not approved	4	$12,322,727	$28,043,158
OECS (Re Antigua and Barbuda, Dominica, Grenada, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and Grenadines)	HIV	RCM	Not approved	3	$3,112,877	$9,059,745
REDCA+ (Re Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama) **	HIV	RO	Approved	2	$2,366,057	$9,229,855
REDLACTRANS (Re Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay)	HIV MARPs	RO	Not approved	3	$4,994,209	$12,500,000
REDTRASEX (Re Argentina, Bolivia, Brazil, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay)	HIV MARPs	RO	Approved	2	$4,328,974	$12,496,279
Total – 15 regional proposals

RO = Regional organisation RCM = Regional coordinating mechanism

* The TRP-recommended funding has been reduced from the requested amount because the TRP removed certain elements from the proposal. ** This is a consolidated proposal. The TRP-recommended funding has been reduced to remove amounts included in the proposal for existing, already funded programmes.

Publication Date: 2010-12-16

Round 10 Results, by Country

N/A

ABSTRACT

ABSTRACT Details are provided of the Board's decision regarding each eligible Round 10 proposal.

Tags:

Leave a reply

Archives

Other Articles from this Issue

Twitter

Facebook

Organization

Contact